Navigation Links
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing
Date:5/16/2013

censing of clinical stage therapeutics. D3 builds on Singapore's existing drug discovery capabilities and strengthens the local biomedical innovation landscape. It was founded to be a cost-effective and professional development partner able to advance and add value to early-stage projects on a 'shared-risk, shared-reward' basis. D3's primary focus is on developing drugs targeted at oncology indications and infectious diseases but the door is open to other indications if a partner brings the necessary disease knowledge. D3 is jointly funded by A*STAR, the Ministry of Health's National Medical Research Council and the National Research Foundation.For more information about D3, please visit http://www.d3.a-star.edu.sg

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a first-in-class immune modulatorin Phase 2 clinical development as a potential new treatment for allergic asthma.

CYT003 acts via a novel, allergen-independent mechanism of action to selectively suppress the body's immune response to allergens, a predominant risk factor for asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function in patients with persistent allergic asthma, even as standard inhaled corticosteroid treatment was withdrawn. CYT003 has been shown to be safe in over 450 patients to date.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tornado Medical Systems And A*STARs Institute Of Microelectronics Partner To Commercialise Nanospectrometers For Optical Coherence Tomography Applications
2. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
3. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
4. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
5. Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
6. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
7. Cardinal Health Brings Resolution to Litigation with DEA Settlement
8. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
9. Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
10. Vocollect Healthcare Systems And Prime Care Technologies Bring AccuNurse Key Performance Metrics To Long-Term Care Providers Via primeVIEW Digital Dashboard
11. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Research and Markets ( ... "Eurpoean Automatic External Defibrillators (AED) Market by ... Market, Hospitals, Alternate Care Market, Home) - Forecast ... The European automated external defibrillator (AED) market ... 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... 31, 2015 Accelerated orthodontic treatment will ... of Orthodontics 2015 Annual Session, May 15-19, as ... lectures on AcceleDent ® . Manufactured by OrthoAccel ... orthodontics, AcceleDent is a FDA-cleared, Class II medical ... much as 50 percent with just 20 minutes ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3AMGA's High Performing Health News Program Features The Medical Letter 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3
... Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and ... (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee ... 01 Blood Glucose Meters as the first and second ... of service as noted by the Uniform Formulary Beneficiary ...
... Oct. 28, 2011 Pearl Therapeutics Inc. presented ... foundations of the Company,s cosuspension technology which uses ... via pressurized metered dose inhalers (MDIs). Two posters ... Association of Pharmaceutical Scientists annual meeting in Washington ...
Cached Medicine Technology:ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary. 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 2Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform 3
(Date:3/31/2015)... Every day a new diet fad is ... things banned in other countries, and the diagnosis of ... Chiropractic & Natural Health Centers believe that by educating ... can reduce the future development of obesity and many ... offers workshops at no charge in their clinics. Because ...
(Date:3/31/2015)... IL (PRWEB) March 31, 2015 As ... Chunk Fitness is pledging to have a mobile-friendly website ... This is part of Chunk Fitness’ continued commitment to ... its growing user base. All of the same great ... available; it will be substantially easier to read while ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Cosmetic ... on the Internet, is proudly enduring adding news to ... doctors and the consumers of plastic surgery and cosmetic ... more user-friendly pages and interconnected sections, the Cosmetic Town ... newest addition to the Cosmetic Town site navigation, News ...
(Date:3/31/2015)... 2015 In conjunction with the ... 1-7, the Mesothelioma Applied Research Foundation (Meso Foundation) ... to complement its existing work in mesothelioma research, ... of the Meso Foundation’s mission, we want to ... related to asbestos, including mesothelioma,” said the Meso ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 In ... (ADS) is offering advice for buying from a ... Dealers Association (NMEDA) is a nonprofit organization that ... in the manufacturing and installation of mobility equipment. ... in the industry that consistently adhere to the ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:Advanced Driving Systems Celebrates National Disability Month 2
... Talisman Ltd., the biomedical,research group and developer ... announce that Exempla Healthcare has contracted to utilize ... Phlebotomy,System(TM) (TPS). QDS automates the gap between ... blood. It utilizes audio-visual touch screen computer,assisted donor ...
... stars are more than twice as likely as the rest ... a few years of becoming famous, reveals research published ahead ... , The findings are based on more than 1050 North ... between 1956 and 1999. , All the musicians featured in ...
... 2007) - - A study from the Monell Chemical ... of lactating mothers who smoke cigarettes disrupts their infants, ... and woke up from naps sooner when their mothers ... Mennella, PhD, a psychobiologist at Monell. , The findings, ...
... A study by UT Southwestern Medical Center researchers has ... care are at high risk for iron deficiency. , ... the study found that 20 percent of overweight toddlers were ... being overweight, and 7 percent of normal-weight toddlers. , ...
... can give rise to exuberant scarring, which can lead ... their disfigurement. In a review article in this weeks ... School of Medicine) and colleagues examine the process of ... and the research areas that are likely to lead ...
... Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) announced today ... granted final approval for the Company,s,Abbreviated New Drug ... (Phentermine HCl). Phentermine HCl is indicated only ... Our generic Phentermine HCl is the,bioequivalent to Adipex-P(R), ...
Cached Medicine News:Health News:Exempla Healthcare Contracts For Talisman's Quality Donor System 2Health News:Pop stars more than twice as likely to die an early death 2Health News:Nicotine in breast milk disrupts infants' sleep patterns 2Health News:Nicotine in breast milk disrupts infants' sleep patterns 3Health News:Overweight toddlers and those not in day care at risk for iron deficiency 2Health News:Overweight toddlers and those not in day care at risk for iron deficiency 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R) 2
For the quantitative determination of creatine kinase in serum. Kinetic Reaction measured at 340 nm. Linearity: 1500 IU/L at 37C....
For the quantitative determination of total glucose in human serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L)....
For the quantitative determination of Glucose in serum. Endpoint Reaction Product measured at 520 nm. Linearity: 500 mg/dl....
Medicine Products: